Lucrezia Raimondi

3PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 30, 2021
Assessment of Resistance Mechanisms and Clinical Implications in Patients with KRAS Mutated-Metastatic Breast Cancer and Resistance to CDK4/6 Inhibitors.

Lucrezia Raimondi, Filippo Maria Raimondi, Marta Pietranera

|Feb 05, 2021
Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review.

Lucrezia Raimondi, Filippo Maria Raimondi, Luigi Rossi

|Sep 23, 2020
PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer.

Lucrezia Raimondi, Filippo Maria Raimondi, Laura Di Benedetto

Pageof 1

Frequent Collaborators

3 joint publications

Gian Paolo Spinelli

1 joint publications

Filippo Maria Raimondi

1 joint publications

Evelina Miele

1 joint publications

Rachele Lazzeroni